Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Risk of Cancer with Combined Oral Contraceptive Use among Iranian Women

  • Vaisy, Afasaneh (Department of Midwifery, Mahabad Branch Islamic Azad University and Department of Pathology, Faculty of Medicin, Urmia University of Medical Sciences) ;
  • Lotfinejad, Shirin (Department of Midwifery, Mahabad Branch Islamic Azad University and Department of Pathology, Faculty of Medicin, Urmia University of Medical Sciences) ;
  • Zhian, Faegh (Department of Midwifery, Mahabad Branch Islamic Azad University and Department of Pathology, Faculty of Medicin, Urmia University of Medical Sciences)
  • Published : 2014.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Oral contraceptive use is the most common type of contraception. More than 300 million women worldwide take oral contraceptives every day. However, there is a concern about the relationship with the incidence of cancer. This analytical retrospective study aimed to investigate the relationship between the incidence of cervical and breast cancers and oral contraceptive use in 128 Iranian patients with cervical cancer, 235 with breast cancer and equal numbers of controls. Data were collected through interviews with an organized set of questions. Details were also extracted from patient files. Data were analyzed using Student's t-test, chi-square and Fisher's exact tests, and Pearson's correlation analysis. The result revealed correlations between both cervical and breast cancers and history of contraceptive pills use. While cervical cancer significantly correlated with duration of use of pills, breast cancer had significant correlations with the type of oral contraceptive and age at first use. No significant relationships were found between the two types of cancer and age at discontinuation of oral contraceptives, patterns of use, and intervals from the last use. The use of oral contraceptives may triple the incidence of cervical cancer and doubles the incidence of breast cancer. Therefore, performing Pap smears every six months and breast cancer screening are warranted for long-term oral contraceptive users.

Keywords

References

  1. Ahmadinejad N, Movahedinia S, Shahriari M (2013). Association of mammographic density with pathologic findings. An Red Crescent Med J, 15, 16698.
  2. Antoine J, Arbyn M, Valerianova Z, et al (2011). Trends in cervical cancer incidence and mortality in Bulgaria and Romania. IJC, 128, 1899-907.
  3. Arbyn M, Saraiya M, Bruni L, et al (2011). World wide burden of cervical cancer in 2008. Oxford J Anno Oncol, 22, 2675-86. https://doi.org/10.1093/annonc/mdr015
  4. Australian Institute of Health and Welfare & Australasian Association of Cancer Registries (2012). Cancer in Australia:an overview. Cancer series no. 74. Cat. no. CAN 70. Canberra: AIHW.
  5. Becker TM, Wheeler CM, McGough NS, et al (1994).Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women. Int J Epidemiol, 23, 913-22. https://doi.org/10.1093/ije/23.5.913
  6. Beiki O, Hall P, Ekbom A, Moradi T (2012). Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study. Breast Cancer Res, 14, 5.
  7. Bhoo-Pathy N, Hartman M, Yip CH, et al (2012). Differences in survival after breast cancer in South East Asia. PLoS One, 7, 30995. https://doi.org/10.1371/journal.pone.0030995
  8. Das S, Sen S, Mukherjee A, Chakraborty D, Mondal PK (2012). Risk factors of breast cancer among women in eastern India:a tertiary hospital based case control study. Asian Pac J Cancer Prev, 13, 4979-81. https://doi.org/10.7314/APJCP.2012.13.10.4979
  9. Dumeaux V, Alsaker E, Lund E (2003). Breast cancer andspecific types of oral contraceptives: a large Norwegian cohort study. Int J Cancer, 105, 844-50. https://doi.org/10.1002/ijc.11167
  10. Ehsanpour S, Nejad FS, Rajabi FM, Taleghani F (2013). Investigation on the association between breast cancer and consumption patterns of combined oral contraceptive pills in the women of Isfahan in 2011. Iran J Nurs Midwifery Res, 18, 186-90.
  11. Eliassen AH, Missmer SA, Tworoger SS, et al (2006).Endogenous steroid hormone concentrations and risk ofbreast cancer among premenopausal women. J Natl Cancer Inst, 98, 1406-15. https://doi.org/10.1093/jnci/djj376
  12. Farajzadegan, Manzouri L, Golmohammadi P (2009). Probability of continuation: with triphasic and monophasic (LD). Shiraz E-Med J, 10, 66-72.
  13. Fasal E, Paffenbarger RS Jr (1975). Oral contraceptives as relatedto cancer and benign lesions of the breast. J Natl Cancer Inst, 55, 767-73.
  14. Foley G, Alston R, Geraci M, et al (2011). Incresing rates of Cervical Cancer in young women in England. Br J Cancer,105, 177-84. https://doi.org/10.1038/bjc.2011.196
  15. Foreman J, Foruzanfar H, Allyne M, et al (2011). Brest andcervical cancer in 187 countries between 1980 and 2010. Lancet, 378, 1461-84. https://doi.org/10.1016/S0140-6736(11)61351-2
  16. Fraumeni Jr, Louise A, Hoover B, Moyses Szklojoseph F (1982).Oral contraceptives and breast cancer. Int J Epidemiol, 11,316-22. https://doi.org/10.1093/ije/11.4.316
  17. Gierisch JM, Coeytaux RR, Urrutia RP, et al (2013). Oralcontraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer EpidemiolBiomarkers Prev, 22, 1931-43.
  18. Health Ministry of Iran (2009). Family planning Office reported.
  19. Imkampe AK, Bates T (2012). Correlation of age at oral contraceptive pill start with age at breast cancer diagnosis. Breast J, 18, 35-40. https://doi.org/10.1111/j.1524-4741.2011.01181.x
  20. Iranian Annual of National Cancer Registration Report, 1999-­2000, Ministry of Health and Medical Education, Center for Disease Control & Prevention. Iran, Tehran.
  21. Iranian Annual of National Cancer Registration Report, 2007-­2008, Ministry of Health and Medical Education, Center for Disease Control & Prevention. Iran, Tehran.
  22. Iranian Annual of National Cancer Registration Report, 2008-­2009, Ministry of Health and Medical Education, Center for Disease Control & Prevention. Iran, Tehran.
  23. Karadag G, Gungormus Z, Surucu R, Savas E, Bicer F (2014). Awareness and practices regarding breast and cervical cancer among Turkish women in Gazientep. Asian Pac J Cancer Prev, 15, 1093-8. https://doi.org/10.7314/APJCP.2014.15.3.1093
  24. Kelsey JL, Gammon MD, John EM (1993). Reproductive factors and breast cancer. Epidemiol Rev, 15, 36-47.
  25. Kumle M, Weiderpass E, Braaten T, et al (2002). Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish women's lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev, 11, 375-81.
  26. La Vecchia C, Negri E, Franceschi S, et al (1995). Oralcontraceptives and breast cancer: a cooperative Italian study. Int J Cancer, 60, 163-7.
  27. Lodha R, Joshi A, Paul D, et al (2011). Association between reproductive factors and breast cancer in an urban set up at central India: a case-control study. Indian J Cancer, 48,303-7. https://doi.org/10.4103/0019-509X.84928
  28. March PA (2002). Oral contraceptives and the risk of breast cancer. N Engle J, 346, 2025-32. https://doi.org/10.1056/NEJMoa013202
  29. Matalqah L, Radaideh K, Yusoff ZM, Awaisu A (2011). Predictors of breast cancer among women in a northern state of Malaysia: a matched case-control study. Asian Pac J Cancer Prev, 12, 1549-53.
  30. Mc Farlane N, Bazuaye PE, Jackson MD, Smikle M, Fletcher HM (2008). Cervical dysplasia and cancer and the use of hormonal contraceptive in jamaican women. BMC Women Health, 8, 9. https://doi.org/10.1186/1472-6874-8-9
  31. Merlo DF, Ceppi M, Filiberti R, et al (2012). Breast cancerincidence trends in European women aged 20-39 years at diagnosis. Breast Cancer Res Treat, 134, 363-70. https://doi.org/10.1007/s10549-012-2031-7
  32. Mousavi SM, Davanlo M, Hajsadeghi N, et al (2007). National Cancer Registry Report 2005-2006. Tehran, Iran: Ministry of Health, Deputy to Health Directory, CDC_Cancer Office;2007. In press.
  33. Mousavi SM, Mohaghegghi MA, Mousavi-Jerrahi A, Nahvijou A, Seddighi Z (2006). Burden of breast cancer in Iran: a study of the Tehran population based cancer registry. Asian Pac J Cancer Prev, 7, 571-4.
  34. Ross J, Winfrey L (2002). Unmet need for contraception in the developing world and the former Soviet union: an updated estimate. Int Family Planning Perspectives, 28, 3.
  35. Sayednozadi SM, Hassany MR, Ramezani MA (2005). Association of oral contraceptives and abnormals pap smear.Am J Applied Sci, 2, 1150-2. https://doi.org/10.3844/ajassp.2005.1150.1152
  36. Shamseddine AI, El Saghir NS, Geara F, et al (2002). Agedistribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation. J Med Liban, 50, 3-9.
  37. Stanford JL, Brinton LA, Daling JR, et al (1995). Oralcontraceptives and breast cancer risk among younger women. J Natl Cancer Inst, 87, 827-35. https://doi.org/10.1093/jnci/87.11.827
  38. Taghavi A, Fazeli Z, Vahedi M, et al (2012). Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev,13, 367-70. https://doi.org/10.7314/APJCP.2012.13.1.367
  39. Taheri NS, Bakhshandehnosrat S, Tabiei MN, et al (2012).Epidemiological pattern of breast cancer in Iranian women: is there an ethnic disparity? Asian Pac J Cancer Prev, 13,4517-20. https://doi.org/10.7314/APJCP.2012.13.9.4517
  40. Tavani A, Negri E, Franceschi S, Parazzini F, La Vecchia C(1993). Oral contraceptives and breast cancer in northern Italy. Final report from a case-control study. Br J Cancer,68, 568-71. https://doi.org/10.1038/bjc.1993.387
  41. Tehranian N, Shobeiri F, Pour FH, Hagizadeh E (2010). Risk factors for breast cancer in Iranian women aged less than 40 years. Asian Pac J Cancer Prev, 11, 1723-5.
  42. Thomas DB (1996). Collaborative study of Neoplasia andsteroid contraceptives oral contraceptive and invasiveadenocarcinoma and adenosquamous cell carcinoma of the uterine cervix. Am J Epidemiol, 144, 281-8. https://doi.org/10.1093/oxfordjournals.aje.a008923
  43. Ursin G, Peters RK, Henderson BE, et al (1994). Oralcontraceptive use and adenocarcinoma of cervix. Lancet,344, 1390-94. https://doi.org/10.1016/S0140-6736(94)90567-3
  44. Wang QS, Ross RK, Yu MC, et al (1992). A case-control study of breast cancer in Tianjin, China. Cancer Epidemiol Biomarkers Prev, 1, 435-9.
  45. Whiteman MK,Wingo PA, Austin H, et al (2007). Oralcontraceptives and the risk of death from breast cancer. Obstet Gynecol, 110, 793-800. https://doi.org/10.1097/01.AOG.0000284446.22251.6e
  46. Wu W, Yin ZH, Guan P, Ren YW, Zhou BS (2014). Association oforal contraceptives use and lung cancer risk among women: an updated meta-analysis based on cohort and case-control studies. Asian Pac J Cancer Prev, 15, 1205-10. https://doi.org/10.7314/APJCP.2014.15.3.1205
  47. Zare N, Haem E, Lankarani KB, Haydari ST, Barooti E (2013). Breast cancer risk factors in a defined population: weighted logistic regression approach for rare events. J Breast Cancer,16, 214-9. https://doi.org/10.4048/jbc.2013.16.2.214
  48. Zechariah Jebakumaret A, Hassan S, Samuel K, et al (2014). Nurses role in cervical cancer prevention and its treatment- Acritical review. Asian Pac J Nurs, 1, 1-5. https://doi.org/10.4103/2347-5625.135799
  49. Zondervan KT, Carpenter LM, Painter R, et al (1996). Oral contraceptives and cervical cancer. Br J Cancer, 73, 1291-7. https://doi.org/10.1038/bjc.1996.247

Cited by

  1. No Increase in Breast Cancer Risk in Japanese Women Taking Oral Contraceptives: a Case-Control Study Investigating Reproductive, Menstrual and Familial Risk Factors for Breast Cancer vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3685
  2. Oral Contraceptives, Abortion and Breast Cancer Risk: a Case Control Study in Saudi Arabia vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3957
  3. Assessing the Acceptability, Feasibility, and Effectiveness of a Tablet-Based Cervical Cancer Educational Intervention vol.32, pp.1, 2017, https://doi.org/10.1007/s13187-015-0953-6
  4. Cervical cancer in Iran: integrative insights of epidemiological analysis vol.8, pp.3, 2018, https://doi.org/10.1051/bmdcn/2018080318
  5. Association of Combined Estrogen–Progestogen and Progestogen-Only Contraceptives with the Development of Cancer vol.85, pp.4, 2018, https://doi.org/10.1177/0024363918811637